BMY - 2 No-Brainer Bio-Tech Stocks to Buy Right Now
It can be scary to put your hard-earned money into a bear market. But it is the right time for growth-oriented investors with a long-term horizon to pounce. Interestingly, there are some stocks, such as biotech companies Exelixis (NASDAQ: EXEL) and Bristol-Myers Squibb (NYSE: BMY) , that are in the limelight by defying the bear market.
While the S&P 500 has plunged 13% so far this year, the shares of Exelixis and Bristol-Myers have surged 15% and 23%, respectively. Let's dive into what these two biotechs have going for them that is attracting investors.
FBIOX Total Return Level data by YCharts
For further details see:
2 No-Brainer Bio-Tech Stocks to Buy Right Now